• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Detection of the c-myc gene product in urinary bladder cancer.膀胱癌中c-myc基因产物的检测
Jpn J Cancer Res. 1990 Dec;81(12):1198-201. doi: 10.1111/j.1349-7006.1990.tb02677.x.
2
Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma.
Cancer Res. 1989 Jul 1;49(13):3627-30.
3
Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.c-myc蛋白的表达与移行细胞膀胱癌中的细胞增殖及生长因子受体的表达相关。
J Pathol. 1995 Feb;175(2):203-10. doi: 10.1002/path.1711750208.
4
Expression of c-erbB-2 gene product in urinary bladder cancer.c-erbB-2基因产物在膀胱癌中的表达。
J Urol. 1991 Feb;145(2):423-7. doi: 10.1016/s0022-5347(17)38356-8.
5
PCNA immunostaining as a valid alternative to tritiated thymidine-autoradiography to detect proliferative cell fraction in transitional cell bladder carcinomas.
In Vivo. 2000 May-Jun;14(3):447-51.
6
An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.膀胱癌患者C-erbB-2基因产物的免疫组织学评估。
Cancer. 1992 Nov 15;70(10):2493-8. doi: 10.1002/1097-0142(19921115)70:10<2493::aid-cncr2820701017>3.0.co;2-k.
7
Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.膀胱移行细胞癌中细胞凋亡、细胞增殖及bcl-2表达的发生率:与肿瘤进展的关联
J Urol. 1996 Jan;155(1):316-20.
8
Expression of ras p21 oncogene product on human bladder tumors.ras p21癌基因产物在人膀胱肿瘤上的表达。
Urol Int. 1989;44(5):260-3. doi: 10.1159/000281520.
9
[Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].[膀胱移行细胞癌中PCNA/细胞周期蛋白、p53、C-erbB-2的表达与组织学分级的关系]
Hinyokika Kiyo. 1995 Apr;41(4):253-8.
10
An immunohistological demonstration of c-erbB-2 oncoprotein expression in primary urothelial bladder cancer.原发性膀胱尿路上皮癌中c-erbB-2癌蛋白表达的免疫组织学证明
Urol Res. 1992;20(2):117-20. doi: 10.1007/BF00296522.

引用本文的文献

1
Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-guérin association.通过膀胱内使用硝唑尼特和卡介苗联合治疗增强膀胱癌治疗效果。
World J Urol. 2021 Apr;39(4):1187-1194. doi: 10.1007/s00345-020-03294-w. Epub 2020 Jun 2.
2
Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.c-Myc免疫组化表达在膀胱肌层浸润性尿路上皮癌中的预后价值:一项回顾性研究
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3735-3746. doi: 10.31557/APJCP.2019.20.12.3735.
3
The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression.通过下调c-myc表达建立生长可控的原位膀胱癌模型。
Oncotarget. 2016 Jul 22;8(31):50500-50509. doi: 10.18632/oncotarget.10784. eCollection 2017 Aug 1.
4
CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.CEBPD在尿路上皮癌中的扩增和过表达:肿瘤转移的驱动因素及不良预后指标
Oncotarget. 2015 Oct 13;6(31):31069-84. doi: 10.18632/oncotarget.5209.
5
Biomarkers in bladder cancer: present status and perspectives.膀胱癌中的生物标志物:现状与展望
Biomark Insights. 2007 Mar 27;2:95-105.
6
[Urine-based diagnostics: an update on the Kiel Tumor Bank].[基于尿液的诊断:基尔肿瘤库的最新进展]
Urologe A. 2009 Jun;48(6):619-24. doi: 10.1007/s00120-009-1991-7.
7
Molecular biomarkers in urothelial bladder cancer.尿路上皮膀胱癌中的分子生物标志物
Cancer Sci. 2008 Apr;99(4):646-52. doi: 10.1111/j.1349-7006.2008.00735.x.
8
[Tumor markers for bladder cancer: up-to-date study by the Kiel Tumor Bank].
Urologe A. 2007 Nov;46(11):1508-13. doi: 10.1007/s00120-007-1562-8.
9
Molecular pathways in bladder cancer.膀胱癌中的分子途径。
Urol Res. 2004 Dec;32(6):373-85. doi: 10.1007/s00240-003-0345-y. Epub 2004 Nov 13.
10
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.在体内顺铂化疗中存活的肿瘤细胞显示出c-myc表达升高。
Br J Cancer. 1996 Mar;73(5):610-4. doi: 10.1038/bjc.1996.105.

本文引用的文献

1
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.淋巴细胞有丝分裂原和血小板衍生生长因子对c-myc基因的细胞特异性调控。
Cell. 1983 Dec;35(3 Pt 2):603-10. doi: 10.1016/0092-8674(83)90092-2.
2
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.由小鼠单克隆抗体所界定的人膀胱癌细胞表面抗原
Proc Natl Acad Sci U S A. 1984 Jan;81(1):224-8. doi: 10.1073/pnas.81.1.224.
3
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.产生一种与细胞增殖相关的人类核抗原有反应性的小鼠单克隆抗体。
Int J Cancer. 1983 Jan 15;31(1):13-20. doi: 10.1002/ijc.2910310104.
4
Identification of nuclear proteins encoded by viral and cellular myc oncogenes.病毒和细胞myc癌基因编码的核蛋白的鉴定。
Nature. 1983;306(5940):274-7. doi: 10.1038/306274a0.
5
Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus.禽骨髓细胞瘤病毒转化基因产物的核定位与DNA结合
Nature. 1982 Mar 18;296(5854):262-9. doi: 10.1038/296262a0.
6
Detection of the c-myc oncogene product in testicular cancer.
Br J Cancer. 1985 Aug;52(2):171-6. doi: 10.1038/bjc.1985.174.
7
c-myc oncogene expression in colorectal cancer.c-myc原癌基因在结直肠癌中的表达
Cancer. 1987 Apr 1;59(7):1289-95. doi: 10.1002/1097-0142(19870401)59:7<1289::aid-cncr2820590710>3.0.co;2-o.
8
Participation of c-myc protein in DNA synthesis of human cells.c-myc蛋白在人类细胞DNA合成中的参与情况。
Science. 1986 Oct 24;234(4775):467-70. doi: 10.1126/science.3532322.
9
Detection of the c-myc oncogene product in colonic polyps and carcinomas.结肠息肉和癌中c-myc癌基因产物的检测。
Br J Cancer. 1986 Jan;53(1):1-6. doi: 10.1038/bjc.1986.1.
10
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.一种c-myc反义寡脱氧核苷酸可抑制进入S期,但不影响从G0期到G1期的进程。
Nature. 1987;328(6129):445-9. doi: 10.1038/328445a0.

膀胱癌中c-myc基因产物的检测

Detection of the c-myc gene product in urinary bladder cancer.

作者信息

Kotake T, Saiki S, Kinouchi T, Shiku H, Nakayama E

机构信息

Department of Urology, Center for Adult Diseases, Osaka.

出版信息

Jpn J Cancer Res. 1990 Dec;81(12):1198-201. doi: 10.1111/j.1349-7006.1990.tb02677.x.

DOI:10.1111/j.1349-7006.1990.tb02677.x
PMID:2125987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918014/
Abstract

Expression of the c-myc gene product in urinary bladder cancer was investigated by immunohistochemical staining with anti-c-myc monoclonal antibody (mAb) MYC-1. Positive staining was observed in the cytoplasm, but not in the nucleus in tissues fixed with 10% formalin. On the other hand, positive staining was localized in the nucleus in cryopreserved tissues. Of 34 cryopreserved specimens examined, positive staining with MYC-1 mAb was observed in 1 of 12 (8.3%) of grade 1 (G1), 12 of 15 (80%) of G2 and 6 of 7 (86%) of G3. Positive staining with Ki-67 mAb was observed in 2 of 12 (17%) of G1, 12 of 15 (80%) of G2, and 6 of 7 (86%) of G3. These results suggest that tumors with higher nuclear pleomorphism contain more proliferating cells.

摘要

采用抗c-myc单克隆抗体(mAb)MYC-1进行免疫组织化学染色,研究c-myc基因产物在膀胱癌中的表达情况。在用10%福尔马林固定的组织中,阳性染色见于细胞质而非细胞核。另一方面,在冷冻保存的组织中,阳性染色定位于细胞核。在检查的34个冷冻保存标本中,1级(G1)的12个中有1个(8.3%)、G2的15个中有12个(80%)、G3的7个中有6个(86%)观察到MYC-1 mAb阳性染色。Ki-67 mAb阳性染色在G1的12个中有2个(17%)、G2的15个中有12个(80%)、G3的7个中有6个(86%)观察到。这些结果表明,核多形性较高的肿瘤含有更多增殖细胞。